Sand Hill Global Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.67M | Sell |
6,617
-376
| -5% | -$80.9K | 0.05% | 112 |
|
|
2026
Q1 | $1.52M | Sell |
6,993
-218
| -3% | -$48.4K | 0.05% | 104 |
|
|
2025
Q4 | $1.65M | Buy |
7,211
+630
| +10% | +$144K | 0.06% | 106 |
|
|
2025
Q3 | $1.52M | Sell |
6,581
-519
| -7% | -$106K | 0.05% | 106 |
|
|
2025
Q2 | $1.32M | Sell |
7,100
-236
| -3% | -$43.9K | 0.05% | 112 |
|
|
2025
Q1 | $1.54M | Buy |
7,336
+222
| +3% | +$43.2K | 0.06% | 103 |
|
|
2024
Q4 | $1.26M | Sell |
7,114
-147
| -2% | -$27K | 0.05% | 108 |
|
|
2024
Q3 | $1.43M | Buy |
7,261
+882
| +14% | +$165K | 0.06% | 100 |
|
|
2024
Q2 | $1.09M | Sell |
6,379
-142
| -2% | -$23.5K | 0.05% | 108 |
|
|
2024
Q1 | $1.19M | Buy |
6,521
+683
| +12% | +$118K | 0.06% | 96 |
|
|
2023
Q4 | $905K | Buy |
5,838
+304
| +5% | +$44.3K | 0.04% | 103 |
|
|
2023
Q3 | $825K | Sell |
5,534
-750
| -12% | -$110K | 0.05% | 97 |
|
|
2023
Q2 | $847K | Sell |
6,284
-12,471
| -66% | -$1.83M | 0.04% | 99 |
|
|
2023
Q1 | $2.99M | Buy |
18,755
+68
| +0.4% | +$10.4K | 0.16% | 72 |
|
|
2022
Q4 | $3.02M | Buy |
18,687
+11,711
| +168% | +$1.8M | 0.17% | 76 |
|
|
2022
Q3 | $936K | Buy |
6,976
+718
| +11% | +$103K | 0.06% | 98 |
|
|
2022
Q2 | $958K | Buy |
6,258
+1,276
| +26% | +$195K | 0.05% | 101 |
|
|
2022
Q1 | $808K | Sell |
4,982
-825
| -14% | -$120K | 0.04% | 96 |
|
|
2021
Q4 | $786K | Hold |
5,807
| – | – | 0.04% | 98 |
|
|
2021
Q3 | $626K | Sell |
5,807
-1,279
| -18% | -$146K | 0.04% | 104 |
|
|
2021
Q2 | $798K | Buy |
7,086
+733
| +12% | +$82.6K | 0.05% | 93 |
|
|
2021
Q1 | $688K | Sell |
6,353
-139
| -2% | -$14.9K | 0.04% | 93 |
|
|
2020
Q4 | $696K | Sell |
6,492
-236
| -4% | -$22.7K | 0.05% | 93 |
|
|
2020
Q3 | $589K | Buy |
6,728
+75
| +1% | +$7.06K | 0.04% | 93 |
|
|
2020
Q2 | $653K | Sell |
6,653
-593
| -8% | -$52.2K | 0.05% | 90 |
|
|
2020
Q1 | $552K | Buy |
7,246
+1,026
| +16% | +$87.4K | 0.05% | 87 |
|
|
2019
Q4 | $551K | Buy |
6,220
+1,890
| +44% | +$157K | 0.05% | 101 |
|
|
2019
Q3 | $328K | Hold |
4,330
| – | – | 0.03% | 115 |
|
|
2019
Q2 | $315K | Buy |
4,330
+1,330
| +44% | +$105K | 0.03% | 92 |
|
|
2019
Q1 | $242K | Sell |
3,000
-52
| -2% | -$4.25K | 0.02% | 98 |
|
|
2018
Q4 | $281K | Buy |
3,052
+52
| +2% | +$4.57K | 0.03% | 93 |
|
|
2018
Q3 | $284K | Sell |
3,000
-100
| -3% | -$9.48K | 0.03% | 90 |
|
|
2018
Q2 | $287K | Sell |
3,100
-1,608
| -34% | -$157K | 0.03% | 90 |
|
|
2018
Q1 | $446K | Sell |
4,708
-134
| -3% | -$14.7K | 0.43% | 50 |
|
|
2017
Q4 | $468K | Buy |
4,842
+1,742
| +56% | +$164K | 0.05% | 79 |
|
|
2017
Q3 | $275K | Buy |
+3,100
| New | +$236K | 0.03% | 94 |
|
Other funds holding ABBV
Sand Hill Global Advisors's ABBV Position: Q2 2026 in Review
Sand Hill Global Advisors reduced its AbbVie (ABBV) stake by 5.4% in Q2 2026, selling an estimated $80.9K and leaving 6,617 shares worth $1.67M. The position accounts for 0.05% of the portfolio, ranked #112.
Sand Hill Global Advisors first reported a position in ABBV in Q3 2017 and has held it in 36 quarters since. The position peaked at $3.02M in Q4 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Sand Hill Global Advisors held 6,617 shares of AbbVie worth $1.67M as of Q2 2026.
- Sand Hill Global Advisors sold 376 AbbVie shares in Q2 2026, an estimated $80.9K.
- AbbVie made up 0.05% of Sand Hill Global Advisors's portfolio in Q2 2026, its #112 holding.
- Sand Hill Global Advisors first reported a position in AbbVie in Q3 2017 and has held it in 36 quarters since.
- Sand Hill Global Advisors's AbbVie position peaked at $3.02M in Q4 2022.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Sand Hill Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.